Xcout Intel
Ocean Biomedical, Inc.
Ocean Biomedical, Inc. operates as a biopharmaceutical firm committed to identifying and advancing novel therapeutic solutions for various medical challenges, including cancer, fibrotic disorders, infectious illnesses, and inflammation. The company's pipeline includes the development of both mono-specific and bi-specific humanized monoclonal antibodies (mAbs). These candidates are specifically designed to target Chi3l1, offering potential treatments for non-small cell lung cancer and glioblastoma multiforme. Additionally, they are progressing a small molecule drug candidate aimed at Chit1, intended to address Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. Leveraging its proprietary WPDS platform, Ocean Biomedical is also developing three further product candidates. These encompass a promising malaria vaccine, a humanized mAb therapeutic for malaria that targets the Plasmodium falciparum glutamic-acid-rich protein (PfGARP), and a small molecule malaria therapeutic also designed to interact with PfGARP. Furthermore, a treatment candidate for hospitalized COVID-19 patients is also under development. The company, established in 2019, maintains its operations in Providence, Rhode Island.
Subscribe to see Ocean Biomedical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ocean Biomedical, Inc. at a glance
Ocean Biomedical, Inc. is a biotech company headquartered in Providence, United States. It is publicly listed (OCEA) with a market capitalisation of $593,177. Xcout tracks 13 named people at Ocean Biomedical, Inc., including Jolie G. Kahn (Chief Financial Officer).
Ocean Biomedical, Inc. leadership
- Jolie G. KahnChief Financial Officer
- Inderjote KathuriaChief Strategy Officer
- Chirinjeev Baboo KathuriaFounder & Executive Chairman of the Board
- Chirinjeev KathuriaDirector
- Elizabeth NgDirector
- Jack A. EliasDirector
7 more named people on record for Ocean Biomedical, Inc., with roles, board committees and tenure — see the full roster →
Get Ocean Biomedical, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ocean Biomedical, Inc. in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access